Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study
Authors
Keywords
-
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-13
DOI
10.1007/s00702-022-02460-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroanatomical changes in early Parkinson’s disease with mild cognitive impairment: a VBM study; the Parkinson’s Disease Cognitive Impairment Study (PaCoS)
- (2021) Giulia Donzuso et al. NEUROLOGICAL SCIENCES
- Cognitive impairment and levodopa induced dyskinesia in Parkinson’s disease: a longitudinal study from the PACOS cohort
- (2021) Antonina Luca et al. Scientific Reports
- Association of lipid levels with motor and cognitive function and decline in advanced Parkinson's disease in the Mark-PD study
- (2021) Chi-un Choe et al. PARKINSONISM & RELATED DISORDERS
- Progression of Nonmotor Symptoms in Parkinson’s Disease by Sex and Motor Laterality
- (2021) Zimple Kurlawala et al. Parkinsons Disease
- Elevated HDL Levels Linked to Poorer Cognitive Ability in Females With Parkinson’s Disease
- (2021) Megan C. Bakeberg et al. Frontiers in Aging Neuroscience
- A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson’s disease
- (2020) Xiaoxue Fu et al. Lipids in Health and Disease
- Serum triglycerides in Alzheimer disease
- (2020) Megan M. Bernath et al. NEUROLOGY
- Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment
- (2020) Congcong Fang et al. Parkinsons Disease
- Cholesterol and Alzheimer’s Disease Risk: A Meta-Meta-Analysis
- (2020) Olalla Sáiz-Vazquez et al. Brain Sciences
- Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study
- (2020) Alessandra Nicoletti et al. JOURNAL OF NEUROLOGY
- Differences in the Presentation and Progression of Parkinson's Disease by Sex
- (2020) Hirotaka Iwaki et al. MOVEMENT DISORDERS
- Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
- (2019) Alessandra Nicoletti et al. Frontiers in Aging Neuroscience
- Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta-analysis of prospective cohort studies
- (2019) Yu Guo et al. MOVEMENT DISORDERS
- Electrocortical networks in Parkinson's disease patients with Mild Cognitive Impairment. The PaCoS study
- (2019) Giovanni Mostile et al. PARKINSONISM & RELATED DISORDERS
- Understanding the links between cardiovascular disease and Parkinson's disease
- (2019) Judy Potashkin et al. MOVEMENT DISORDERS
- Cardiovascular autonomic function and MCI in Parkinson's disease
- (2019) Calogero Edoardo Cicero et al. PARKINSONISM & RELATED DISORDERS
- Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)
- (2018) Roberto Monastero et al. JOURNAL OF NEUROLOGY
- Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
- (2018) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Higher serum triglyceride levels are associated with Parkinson's disease mild cognitive impairment
- (2018) Xinxin Huang et al. MOVEMENT DISORDERS
- Sex-specific nonlinear associations between serum lipids and different domains of cognitive function in middle to older age individuals
- (2017) Yanhui Lu et al. METABOLIC BRAIN DISEASE
- Triglycerides are negatively correlated with cognitive function in nondemented aging adults.
- (2017) Vishnu Parthasarathy et al. NEUROPSYCHOLOGY
- Gender effect on non-motor symptoms in Parkinson's disease: are men more at risk?
- (2017) A. Nicoletti et al. PARKINSONISM & RELATED DISORDERS
- Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson’s Disease
- (2016) Aging and Disease
- Role of the blood-brain barrier in the evolution of feeding and cognition
- (2012) William A. Banks Annals of the New York Academy of Sciences
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- The Frontal Assessment Battery (FAB) in Parkinson’s disease and correlations with formal measures of executive functioning
- (2008) C. F. Lima et al. JOURNAL OF NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started